AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Calvert, PD Krasnoperova, NV Lyubarsky, AL Isayama, T Nicolo, M Kosaras, B Wong, G Gannon, KS Margolskee, RF Sidman, RL Pugh, EN Makino, CL Lem, J
Citation: Pd. Calvert et al., Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha-subunit (vol 97, pg 13913, 2000), P NAS US, 98(18), 2001, pp. 10515-10515

Authors: Shelton, RC Tollefson, GD Tohen, M Stahl, S Gannon, KS Jacobs, TG Buras, WR Bymaster, FP Zhang, W Spencer, KA Feldman, PD Meltzer, HY
Citation: Rc. Shelton et al., A novel augmentation strategy for treating resistant major depression, AM J PSYCHI, 158(1), 2001, pp. 131-134

Authors: Street, JS Tollefson, GD Tohen, M Sanger, TM Clark, WS Gannon, KS Wei, HX
Citation: Js. Street et al., Olanzapine for psychotic conditions in the elderly, PSYCHIAT AN, 30(3), 2000, pp. 191-196

Authors: Calvert, PD Krasnoperova, NV Lyubarsky, AL Isayama, T Nicolo, M Kosaras, B Wong, G Gannon, KS Margolskee, RF Sidman, RL Pugh, EN Makino, CL Lem, J
Citation: Pd. Calvert et al., Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha-subunit, P NAS US, 97(25), 2000, pp. 13913-13918

Authors: Street, JS Clark, WS Gannon, KS Cummings, JL Bymaster, FP Tamura, RN Mitan, SJ Kadam, DL Sanger, TM Feldman, PD Tollefson, GD Breier, A
Citation: Js. Street et al., Olanzapine treatment of psychotic and behavioral symptoms in patients withAlzheimer disease in nursing care facilities - A double-blind, randomized,placebo-controlled trial, ARCH G PSYC, 57(10), 2000, pp. 968-976
Risultati: 1-5 |